Jyothi Datta is a journalist for businessline, covering a wide range of topics including healthcare, pharmaceuticals, and business. With a focus on providing in-depth analysis and reporting on current issues, Jyothi's articles aim to inform and educate readers on the latest developments in the industry.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Jyothi Datta's coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on COVID-19, medical research, vaccines, public health, and healthcare. She frequently covers government announcements and press releases in her articles.
Given the nature of Jyothi's coverage, she would likely be interested in pitches that offer expert insights into the latest developments in healthcare policies or breakthroughs in medical research. Furthermore, sources who can provide data-driven analysis related to public health trends or vaccine efficacy may find success when reaching out to Jyothi.
Although no specific geographic focus is indicated for Jyothi's coverage attributes suggests that she takes an international view of healthcare topics. Therefore, experts from around the world could potentially engage effectively with her through relevant and insightful pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jyothi Datta
VAV Life Sciences collaborates with Aurolab Trust, manufacturing arm of Aravind Eye Hospital. on the product
The United States congressional subcommittee's final report on the Covid-19 pandemic has pointed to the “lab leak” theory, making it the latest US report pinning the origins of the SARS-CoV-2 virus to the Wuhan lab in China.
Union Health Ministry reconstitutes Central Expert Committee to address faulty ASR hip-implants issue and determine compensation for patients.
By: Jyothi Datta
The board of Metropolis Healthcare has approved the acquisition of Delhi's Core Diagnostics for ₹246.8 crore, making it a leading cancer testing
By: Jyothi Datta
An “inhaled insulin” is set to join the repertoire of options available to people with diabetes, as drugmaker Cipla completes last mile procedures to import Afrezza from US' MannKind Corporation.
On December 26, 2004, India issued the Patents (Amendment) Ordinance, paving the way for an ecosystem that would eventually recognise product patents from January 1, 2005.
By: Jyothi Datta
Global geo-political concerns and shifting policies in the United States have not dampened opportunities for contract development and manufacturing
By: Jyothi Datta
The complaint was that the company had provided travel tickets and hotel accommodation for extravagant pleasure trips under the guise of conferences in February and March 2024
By: Jyothi Datta
The first order under the Centre's updated Uniform Code for Pharmaceutical Marketing Practices (2024) has the Department of Pharmaceuticals (DoP) and
By: Jyothi Datta, Amitha Rajkumar
In this episode of the State of the Economy podcast, businessline's Jyothi Dutta talks to Biswajit Dhar, Professor, Jawaharlal Nehru University (Retd) and
(833) 317-6278 
